The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Khan, Mohammed Sahad
    Director born in August 1984
    Individual (1 offspring)
    Officer
    2015-10-15 ~ dissolved
    OF - Director → CIF 0
Ceased 4
  • 1
    Khan, Adil Mehmood
    Individual (14 offsprings)
    Officer
    2004-06-01 ~ 2013-01-01
    OF - Secretary → CIF 0
  • 2
    Khan, Sajid
    Pharmacist born in September 1978
    Individual (61 offsprings)
    Officer
    2004-06-01 ~ 2011-05-14
    OF - Director → CIF 0
    Khan, Sajid
    Director born in September 1978
    Individual (61 offsprings)
    2011-05-14 ~ 2015-10-15
    OF - Director → CIF 0
  • 3
    39a Leicester Road, Salford, Manchester
    Dissolved Corporate (2 parents, 2 offsprings)
    Officer
    2004-05-14 ~ 2004-05-18
    PE - Nominee Director → CIF 0
  • 4
    39a Leicester Road, Salford, Manchester
    Dissolved Corporate (2 parents, 9 offsprings)
    Officer
    2004-05-14 ~ 2004-05-18
    PE - Nominee Secretary → CIF 0
    PE - Nominee Secretary → CIF 0
parent relation
Company in focus

AVERROES PHARMACY LTD.

Previous name
AVICENNA PHARMACY LIMITED - 2005-08-16
Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Par Value of Share
Class 1 ordinary share
1 GBP2014-06-01 ~ 2015-05-31
Tangible fixed assets
229,941 GBP2015-05-31
288,540 GBP2014-05-31
Inventory/Stocks
63,600 GBP2015-05-31
361,794 GBP2014-05-31
Debtors
1,972,226 GBP2015-05-31
1,849,278 GBP2014-05-31
Cash at bank and in hand
1,204 GBP2015-05-31
395,090 GBP2014-05-31
Current Assets
2,037,030 GBP2015-05-31
2,606,162 GBP2014-05-31
Current liabilities
770,877 GBP2015-05-31
2,120,442 GBP2014-05-31
Net Current Assets/Liabilities
1,266,153 GBP2015-05-31
485,720 GBP2014-05-31
Total Assets Less Current Liabilities
1,496,094 GBP2015-05-31
774,260 GBP2014-05-31
Non-current liabilities
499,709 GBP2014-05-31
Net assets/liabilities including pension asset/liability
1,496,094 GBP2015-05-31
274,551 GBP2014-05-31
Called-up share capital
100 GBP2015-05-31
100 GBP2014-05-31
Retained earnings
1,495,994 GBP2015-05-31
274,451 GBP2014-05-31
Shareholder's fund
1,496,094 GBP2015-05-31
274,551 GBP2014-05-31
Cost/valuation of tangible fixed assets
442,131 GBP2015-05-31
427,401 GBP2014-05-31
Depreciation of tangible fixed assets
212,190 GBP2015-05-31
138,861 GBP2014-05-31
Depreciation expense of tangible fixed assets in the period
73,329 GBP2014-06-01 ~ 2015-05-31
Number of shares allotted
Class 1 ordinary share
100 shares2015-05-31
Paid-up share capital
Class 1 ordinary share
100 GBP2015-05-31
100 GBP2014-05-31

  • AVERROES PHARMACY LTD.
    Info
    AVICENNA PHARMACY LIMITED - 2005-08-16
    Registered number 05128805
    38 De Montfort Street, Leicester, Leicestershire LE1 7GS
    Private Limited Company incorporated on 2004-05-14 and dissolved on 2020-11-19 (16 years 6 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.